XML 12 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Income - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Net sales $ 279.3 $ 256.4 $ 795.0 $ 784.3
Cost of products sold 199.1 184.2 566.2 565.2
Gross profit 80.2 72.2 228.8 219.1
Selling expense 9.0 8.6 27.3 25.8
Research and development expense 3.6 3.1 10.4 10.1
General expense 24.6 24.3 77.9 72.0
Total nonmanufacturing expenses 37.2 36.0 115.6 107.9
Restructuring and impairment expense 6.0 1.6 7.7 2.0
Operating profit 37.0 34.6 105.5 109.2
Interest expense 7.8 6.7 22.8 29.6
Other (expense) income, net (1.0) 1.7 (0.7) (1.6)
Income from continuing operations before income taxes and income from equity affiliates 28.2 29.6 82.0 78.0
Provision for income taxes 4.8 3.2 15.5 12.8
Income from equity affiliates, net of income taxes 1.1 1.3 2.0 0.4
Income from continuing operations 24.5 27.7 68.5 65.6
Net income $ 24.5 $ 27.7 $ 68.5 $ 65.6
Net income per share - basic:        
Income per share from continuing operations (in dollars per share) $ 0.78 $ 0.90 $ 2.19 $ 2.13
Net income per share - basic (in dollars per share) 0.78 0.90 2.19 2.13
Net income per share – diluted:        
Income per share from continuing operations (in dollars per share) 0.78 0.90 2.18 2.12
Net income per share - diluted (in dollars per share) $ 0.78 $ 0.90 $ 2.18 $ 2.12
Weighted average shares outstanding:        
Basic (in shares) 30,909,700 30,662,800 30,805,300 30,648,400
Diluted (in shares) 31,142,500 30,831,900 31,020,100 30,804,700